ArticleFuture oncology (London, England)2025
Oncologists' preferences for frontline TKI treatment of Ph+ acute lymphoblastic leukemia: a discrete choice experiment.
Ajibade Ashaye et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.